Atlas Trials

Long-term Safety Study of Treatment With the Thrombopoietin Agonists Eltrombopag and Romiplostim in Patients With Immune Thrombocytopenia (ITP)

Clinical trial NCT01443351 · WITHDRAWN

Trial details

NCT number
NCT01443351
Sponsor
Zealand University Hospital
Status
WITHDRAWN
Study type
OBSERVATIONAL
Idiopathic Thrombocytopenic Purpura
Start date
2015-03-01
Primary completion
2019-08-01
Enrollment
0

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.